CUROSURF 240 mg
Home - Curosurf
Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and ... - Nanoscale (RSC Publishing) DOI:10.1039/C5NR01496D
PDF) Safety and efficacy of a novel double-lumen tracheal tube in neonates with RDS: A prospective cohort study
Home - Curosurf
Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and ... - Nanoscale (RSC Publishing) DOI:10.1039/C5NR01496D
Curosurf
PDF) Lung Deposition of Surfactant Delivered via a Dedicated Laryngeal Mask Airway in Piglets
Curosurf ® 120 mg/1.5 ml
Home - Curosurf
917_curosurf_logo.jpg
PDF) Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome
PDF) Nasal high flow therapy in very low birth weight infants with mild respiratory distress syndrome: A single center experience
Effect of pulmonary surfactant on the dissolution, stability and uptake of zinc oxide nanowires by human respiratory epithelial cells. - Abstract - Europe PMC
Effect of pulmonary surfactant on the dissolution, stability and uptake of zinc oxide nanowires by human respiratory epithelial cells. - Abstract - Europe PMC
PDF) The Role of Surfactant in Respiratory Distress Syndrome
PDF) The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
CHIESI USA, Inc.
548_curosurf-double.jpg
Curosurf
Curosurf ® 240 mg/3 ml
Ioannis Boras - Greece | Professional Profile | LinkedIn
PDF) Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants
PDF) Nasal high flow therapy in very low birth weight infants with mild respiratory distress syndrome: A single center experience
